Health-care companies rose slightly ahead of earnings in the sector. Shares of Revolution Medicines tumbled after The Wall Street Journal reported that Merck had cut off talks with the cancer-drug ...
This drugmaker continues to strengthen its investment thesis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results